The role of inflammation in the pathogenesis of heart failure (Q34605371)

3 August 2017

1 reference

title

The role of inflammation in the pathogenesis of heart failure (English)

1 reference

3 August 2017

0 references

1 reference

Guillermo Torre-Amione

5

object named as

Guillermo Torre-Amione

1 reference

3 August 2017

Kevin A Lisman

1

1 reference

3 August 2017

Sonny J Stetson

2

1 reference

3 August 2017

Michael M Koerner

3

1 reference

3 August 2017

John A Farmer

4

1 reference

3 August 2017

1 May 2002

1 reference

Current cardiology reports

3 August 2017

1 reference

3 August 2017

4

1 reference

3 August 2017

3

1 reference

3 August 2017

200-205

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-002-0051-3

3 August 2017

0 references

cites work

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0051-3

Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0051-3

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0051-3

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0051-3

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

21 January 2018

1 reference

12 December 2020

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

12 December 2020

Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery

1 reference

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

12 December 2020

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

12 December 2020

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

12 December 2020

Mechanisms of action of intravenous immune globulin in immune-mediated diseases

1 reference

12 December 2020

The effect of VAS972 on allergic contact hypersensitivity

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

1 reference

12 December 2020

Expression and functional significance of tumor necrosis factor receptors in human myocardium

1 reference

12 December 2020

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

12 December 2020

10.1007/S11886-002-0051-3

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference